| Affiliation: | 1. I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;2. Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;3. Institute of Internal Medicine and Hepatology, Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece;4. Department for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Bologna, Italy;5. Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;6. Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy;7. European Reference Network on Hepatological Diseases (ERN RARE-LIVER);1. European Foundation for Study of Chronic Liver Failure, EF-Clif, Barcelona, Spain;2. JW Goethe University Hospital, Frankfurt, Germany;3. Hospital Clinic of Barcelona, Barcelona, Spain;1. Section of Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX Center, Houston, Texas, United States of America;2. Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States of America;3. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America;1. Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBEREHD, Universidad de Alcalá, Madrid, Spain;2. Department of Digestive Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (iISGM), CIBEREHD, and Facultad de Medicina, Universidad Complutense de Madrid, Spain;1. Institute of Biochemistry, Christian-Albrechts-University Kiel, Germany;2. Institute of Immunology, University Medical Center Hamburg-Eppendorf, Germany;3. Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Germany;4. Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Germany;5. Department of Medicine I, University Medical Center Hamburg-Eppendorf, Germany;6. Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic;7. Infection Immunology, Research Center Borstel, Leibniz Lung Center, Germany;8. Max-Planck Institute for Metabolism Research, Cologne, Germany;9. Martin Zeitz Center for Rare Diseases;1. The Kirby Institute, UNSW Sydney, Sydney, Australia;2. Department of Health Systems and Populations, Maquarie University, Sydney, Australia;3. British Columbia Centre for Disease Control, Vancouver, Canada;4. School of Population and Public Health, University of British Columbia, Vancouver, Canada;5. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada;6. Storr Liver Centre, Westmead Millennium Institute, University of Sydney and Westmead Hospital, Westmead, Australia;7. National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia |
